AstraZeneca invests €65M in Alexion Irish plants in Dublin and Athlone

AstraZeneca is investing an additional €65 million to upgrade Alexion's drug substance production facilities in Dublin and Athlone, Ireland, including new machinery and a production and science technology lab.

“The company now claims to be investing an additional 65 million euros ($68.7 million) in the location and an Alexion plant in Ireland’s Athlone, 120 kilometres to the west.”worldpharmatoday.com

• 1 source
• worldpharmatoday.comAlexion Irish Factory Gets A .7M Upgrade From AstraZenecacontentJun 27, 2022

Summarized from public sources; check the original articles before acting on it.